BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

CVBT-141B: Phase IIa data

In a double-blind Phase IIa trial, CVBT-141B healed diabetic wounds about 4.5 times faster than placebo plus standard of care. No significant drug-related adverse events were...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >